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Lysophospholipids are important signaling molecules in animals and metazoan cells. They
are widely distributed among marine invertebrates, where their physiological roles are
unknown. Sea cucumbers produce unique lysophospholipids. In this study, two lysopho-
spholipids were detected in Holothuria atra for the first time, lyso-platelet activating factor
and lysophosphatidylcholine, with nuclear magnetic resonance and liquid chromatography–
time-of-flight mass spectrometric analyses. The lipid fraction of H. atra contained lyso-plate-
let activating factor and lysophosphatidylcholine, and inhibited H2O2-induced apoptosis in
the macrophage cell line J774A.1. The antioxidant activity of the lysophospholipid-contain-
ing lipid fraction of H. atra was confirmed with the oxygen radical absorbance capacity
method. Our results suggest that the lysophospholipids from H. atra are potential therapeu-
tic agents for the inflammation induced by oxidative stress.
Introduction
Biologically active products from marine organisms have recently become the focus of pharma-
ceutical research and health food development. Among the aquatic invertebrates, sea cucum-
bers produce a diversity of secondary metabolites with valuable biological activities. The sea
cucumber, Holothuria, which belongs to the phylum Echinodermata and the class Holothuroi-
dea, is found on seafloors throughout the world [1]. It is considered a healthy food because it
contains various physiologically active substances, including vitamins (A, C, B1, B2, and B3),
trace elements (calcium, iron, magnesium, and zinc), polysaccharides (chondroitin sulfate),
and saponin glycosides [2]. Sea cucumbers are also commonly used to treat wounds, eczema,
arthritis, hypertension, and impotence [3].
Some bioactive compounds extracted from sea cucumbers are reported to have anti-inflam-
matory [4], antitumor [5], and fungicidal activities [6]. For instance, the sphingoid base
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composition of cerebrosides prepared from the sea cucumber is cytotoxic to human colon cancer
cell lines [7]. Holotoxins from sea cucumbers are also well-known antifungal glycosides [8,9].
The characteristics of glycosphingolipids and their structure–activity relationships conferred
neuritogenic activity against the rat pheochromocytoma cell line PC12 [10]. Further novel bioac-
tive products may be discovered in the sea cucumber. In this study, we investigated the lipids of
Holothuria atra, which is reported to have medicinal value [11]. A mixed extract ofH. atra con-
tained physiologically active phenolic compounds with antioxidant activity, which exerted potent
hepatoprotective effects against thioacetamide-induced liver injury in a rat model [3]. Therefore,
we undertook this study to identify the bioactive lipids in a mixed extract of theH. atra body wall
and to evaluate their cytoprotective potential against oxidative stress. We found that lysopho-
spholipids fromH. atra inhibit H2O2-induced apoptosis in macrophages.
Materials and Methods
Ethics statement
Sea cucumbers were sampled after the appropriate permission was obtained from the Fisher-
men’s Cooperative Association in Okinawa Prefecture.
Extraction and purification of lipids from H. atra
Sea cucumbers (H. atra) were collected from the ocean at Okinawa, Japan, and transported fro-
zen on dry ice to our laboratory. The whole tissues (792.3 g) were homogenized in a blender
with 1.5 L of chloroform–methanol (1:2, v/v) and mixed for 1 h at room temperature. The
extract was filtered under reduced pressure to produce an aqueous suspension. The residue
remaining after filtering was treated with 1.5 L of chloroform–methanol mixtures (1:4 and
then 2:1, v/v) for 1 h each at room temperature, and the aqueous suspension was collected as
described above. The aqueous suspension of the whole tissues was treated overnight with chlo-
roform–methanol–water (8:4:3, v/v) using the Folch method. The lipid layer from the whole
tissues was mixed to form the total lipid (TL).
The TL (8.965 g) was applied to a silica-gel column (Wakogel C-200, diameter 4 cm, height
40 cm, volume 502.4 cm3; Wako Pure Chemical, Osaka, Japan) in chloroform and eluted
sequentially with chloroform–methanol (4:1, 2:1, 1:1, and 1:4, v/v), methanol, chloroform–
methanol–water (3:6:1, v/v), and chloroform–water (4:1, v/v).
To detect the lipids, the TL was analyzed with silica gel thin-layer chromatography (TLC;
silica gel 60, 0.25 mm; Merck, Darmstadt, Germany) with a chloroform–methanol–water mix-
ture (65:25:4 or 65:35:8, v/v/v). The lipid species were visualized by spraying the plate with 50%
sulfuric acid and heating it briefly. The carbohydrates and phospholipids were detected on the
TLC plate with anthrone–sulfuric acid reagent and Dittmer reagent, respectively.
The fractionated lipids were evaporated with N2 and suspended in Tocrisolve 100 (Tocris
BioScience, Bristol, UK) at 200 mg/mL.
Reagents
Lyso-platelet activating factor (Lyso-PAF C18:0 and (9Z)-C18:1) were purchased from Avanti
Polar Lipids (Alabaster, AL). Lysophosphatidylcholine (LPC, C18:0) and sphingomyelin were
from Sigma (St Louis, MO).
Measurement of cell viability
The mouse macrophage cell line J774A.1 (ATCC TIB-67) was cultured in Dulbecco’s modified
Eagle’s medium (Sigma) supplemented with 10% heat-inactivated fetal bovine serum. The
Lysophospholipids from Sea Cucumber
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J774A.1 cells were seeded in 96-well flat-bottom plates (3.8 × 105 cells/mL), incubated over-
night at 37°C., and then preincubated with the lipids for 12 h. To induce apoptosis, the cells
were treated with 112.5 μM or 25 μMH2O2. After 12 h, 2-(4-iodophenyl)-3-(4-nitrophenyl)-5-
(2,4-disulfophenyl)-2H-tetrazolium monosodium salt and 1-methoxy-5-methylphenazinium
methyl sulfate (Cell Counting Kit-8; Dojin Laboratories, Kumamoto, Japan) were added to
final concentrations of 5 mM and 0.2 mM, respectively, and the cells were incubated for
another 4 h. Proliferation was measured as the mean absorbance at 450 nm. Cell viability was
expressed as the relative absorbance of the lipid-treated cells normalized to the absorbance of
the untreated control cells (×100).
Detection of apoptotic cells using terminal deoxynucleotidyl transferase
(TdT)-mediated dUTP–biotin nick-end labeling (TUNEL)
To detect apoptosis directly, the cells were analyzed with TUNEL (In Situ Cell Death Detection
Kit, TMR red; Roche Diagnostics GmbH, Mannheim, Germany). Briefly, the cells were placed
on glass slides and dried. They were then fixed with 4% paraformaldehyde in phosphate-buff-
ered saline (PBS) for 30 min at room temperature, washed in PBS, and permeabilized with
0.1% Triton X-100 in 0.1% sodium citrate for 2 min at 4°C. TdT labeling was performed with
the commercially available kit, according to the manufacturer’s protocol. The apoptotic cells
were directly detectable by their red color with fluorescence microscopy (Eclipse E400, Nikon
Inc., Melville, NY). The images were captured with a CCD camera and processed with a digital
fluorescence microscope (VB-6000, Keyence, Osaka, Japan).
Nuclear magnetic resonance (NMR)
All NMR experiments were performed with a JEOL ECA-600 NMR spectrometer with a 5 mm
inverse triple-resonance 1H/13C/X probe, with a z-axis pulsed-field gradient for two-dimensional
(2D) experiments or with a 5 mm tunable double-resonance probe for 1D experiments, operating
at 600.17 MHz for 1H, 150.91 MHz for 13C, and 242.95MHz for 31P at 298 K. The 1H chemical
shift was referenced to the residual CD2HOD signal at 3.30 ppm. The
13C chemical shift was ref-
erenced to the solvent CD3OD signal at 49.0 ppm. The
31P chemical shift was referenced to an
external reference of 85% H3PO4 at 0.0 ppm. The NMR spectra were measured and processed
using a standard pulse sequence and the Delta version 5.0 software (JEOL, USA).
Liquid chromatography and time-of-flight mass spectrometry (LC/
TOF-MS)
The seventh lipid fraction (F7) was injected into the mass spectrometer with a high-pressure
LC system (Acquity UPLC System; Waters, MA), with a BEH C18 column (2.1 × 50 mm,
1.7 mm) at a flow rate of 0.25 mL/min. Gradient elution was conducted with mobile phases A
(0.1% formic acid in water) and B (acetonitrile). The gradient used commenced with 40%
mobile phase B, isocratic for 0.7 min; increased to 90% B over 5.3 min; isocratic for 2.5 min;
and then back to 40% B over 0.5 min. All mass spectrometric analyses were performed with the
SYNAPT G2 HDMS platform (Waters, Manchester, UK). A voltage (3.0 kV) was applied to
the stainless steel electrospray ionization (ESI) capillary under positive ion conditions. The
TOF analyzer was set to resolution mode with a resolving power of 20,000 atm/z 556 (leucine
enkephalin) and them/z range of 50–1500 was calibrated with sodium formate. The capillary,
extraction cone, and cone voltages were set to 3 kV, 104 kV, and 4 kV, respectively. The deso-
lvation gas (nitrogen) was used at a flow rate of 800 L/h, and the source and desolvation tem-
peratures were set to 100°C and 250°C, respectively.
Lysophospholipids from Sea Cucumber
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Ozonolysis
Excess ozone was passed through a solution of the F7 lipid fraction (1.6 mg) in CD3OD (1.1 mL)
at –78°C for 1.1 h. After nitrogen gas was bubbled through the solution for 10 min to remove the
excess ozone, dimethyl sulfide (0.5 mL) was added slowly with stirring at –78°C. The mixture
was allowed to warm gradually to room temperature and stirring was continued overnight. An
aliquot (0.2 mL) was analyzed with LC/TOF-MS, and the remaining solution was concentrated
to a syrupy gum (1.0 mg) in vacuo.
Oxygen radical absorbance capacity (ORAC) assay
The ORAC assay was performed in triplicate on standard lipids and the extracts, according to the
manufacturer’s recommendations (OxiSelect ORACActivity Assay Kit; Cell Biolabs, San Diego,
CA). The diluted samples (0, 2.5, 5, 10, 20, 30, 40, and 50 μM) were analyzed in triplicate in a
96-well plate. To each well were added 150 μL of fluorescein solution (0.036 mg/L; Cell Biolabs)
and 25 μL of the diluted sample or 25 μL of the Trolox standard (6-hydroxy-2,5,7,8-tetramethyl-
croman-2-carboxylic acid; Cell Biolabs), and the plate was incubated for 30 min at 37°C, after
which 25 μL of 2,20-azobis-2-aminopropane dihydrochloride (AAPH) solution (80 mg/mL; Cell
Biolabs) was added. The ORAC assay quantifies the inhibition (expressed as a percentage over
time) of the fluorescence produced by peroxyl radicals generated at a constant rate by the thermal
decomposition of AAPH. The antioxidant capacity is expressed in μmol Trolox equivalents
(TE)/g, and is calculated from a Trolox standard curve.
Statistical analysis
All statistical analyses were performed with the GraphPad Prism 5 software (GraphPad Soft-
ware Inc., La Jolla, CA). The results are presented as means ± standard deviations. The signifi-
cance of differences was evaluated with one-way analysis of variance (ANOVA) followed by
Tukey’s multiple comparisons procedure or Student’s t test.
Results
Lipid fraction extracted with chloroform–water (4:1, v/v) prevented H2O2-
induced cell death
Fig 1A shows the seven lipid fractions (F1–F7) eluted sequentially from a silica gel column
with the following eluents: chloroform–methanol (4:1, 2:1, 1:1, 1:4, v/v), methanol, chloro-
form–methanol–water (3:6:1, v/v), and chloroform–water (4:1, v/v), respectively. We tested the
protective activities of these lipid fractions in J774A.1 cells treated with H2O2 (Fig 1B). Pre-
treatment of the cells with TL fromH. atra inhibited H2O2-induced cell death compared with
that in the control cells treated with H2O2 only. The F1, F3, F4, F6, and F7 lipid fractions signif-
icantly protected the J774A.1 cells from H2O2 stress. Because F7 appeared as a single spot on
TLC, we characterized this fraction in a further experiment. As shown in Fig 2, H2O2 treatment
induced apoptosis in the J774A.1 cells of the control group. However, treatment with the F7
lipid fraction inhibited the apoptosis induced by H2O2. These results suggest that the F7 lipid
fraction had antiapoptotic activity.
Characterization of the lipid fraction extracted with chloroform–water
(4:1, v/v)
To examine the contents of the F7 fraction, TLC using anthrone–sulfuric acid reagent and Ditt-
mer reagent was performed to detect the carbohydrates and phospholipids, respectively, and
Lysophospholipids from Sea Cucumber
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50% sulfuric acid was used to detect organic compounds. The anthrone–sulfuric acid reagent
did not detect the spot of the F7 fraction or that of sphingomyelin, Lyso-PAF, or LPC. How-
ever, the spot of the F7 fraction was detected with Dittmer reagent, with Rf values similar to
Fig 1. Thin-layer chromatogram (TLC) and cytoprotective effects of the lipids extracted fromHolothuria atra. (A) TLC analysis of the lipids extracted
from H. atra using a chloroform–methanol–water mixture (65:25:4, v/v/v). The total lipid (TL) was applied to a silica gel column in chloroform and eluted with:
(F1) chloroform–methanol (4:1 v/v); (F2) chloroform–methanol (2:1 v/v); (F3) chloroform–methanol (1:1 v/v); (F4) chloroform–methanol (1:4 v/v); (F5)
methanol; (F6) chloroform–methanol–water (3:6:1 v/v); or (F7) chloroform–water (4:1 v/v). (B) Viability of J774A.1 cells treated with the extracted lipids.
J774A.1 cells were preincubated with each lipid fraction (10 μg/mL) for 12 h. H2O2 was then added to the cells (112.5 μM). After 12 h, cell viability was
measured and expressed as the mean viability ± standard deviation of triplicate experiments. (*) According to Student’s t test, the difference between the
lipid-treated cells and the untreated cells (control) was significant (P < 0.05).
doi:10.1371/journal.pone.0135701.g001
Lysophospholipids from Sea Cucumber
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those for LPC and Lyso-PAF, but not with an Rf value similar to that of sphingomyelin (Fig 3),
indicating the presence of phospholipids in the F7 fraction.
Fig 2. Antiapoptotic activity of the F7 fraction in H2O2-treated cells. J774A.1 cells were preincubated
with the F7 lipid fraction for 12 h. H2O2 was then added to the cells (112.5 μM). After 12 h, the TUNEL-positive
cells were quantified and the results expressed as the mean ± standard deviation of triplicate experiments.
(A) TUNEL staining of J774A.1 cells treated with the F7 lipid fraction. (B) Frequency of apoptosis. (*)
According to Student’s t test, the difference between the lipid-treated cells and untreated cells (control) was
significant (P < 0.05).
doi:10.1371/journal.pone.0135701.g002
Lysophospholipids from Sea Cucumber
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To analyze the phospholipids in the F7 fraction, we performed detailed NMR experiments,
including 2D NMR with DQF-COSY, TOCSY, NOESY, HSQC, HSQC-TOCSY, 1H-13C
HMBC, and 1H-31P HMBC (S1 File) [12]. The 1H NMR spectrum of the F7 fraction was quite
similar to that of authentic Lyso-PAF (9Z)-C18:1. However, the integration values for the ole-
finic methine and allylic methylene signals were only half those expected for Lyso-PAF C18:1,
and there were small minor signals. This indicates that the F7 fraction was a mixture of satu-
rated and unsaturated Lyso-PAF, with minor amounts of other lipids. The connectivity
between the glycerol unit and the alkyl chain portion through the ether bond in the Lyso-PAF
structure was determined from long-range correlations in the 1H-13C HMBC spectra. The
presence of a choline unit and the connectivity between the choline and glycerol units through
phosphate were confirmed with NOESY, 1H-13C HMBC, and 1H-31P HMBC spectral data.
However, it was difficult to clarify the double bond position with TOCSY, HSQC-TOCSY, and
HMBC. A direct comparison showed that the 13C NMR spectrum of the F7 fraction was not
identical to that of Lyso-PAF (9Z)-C18:1, whereas it closely matched the 13C signals from the
C7–C12 portion of cis-5-dodecenoic acid, used as a model of the (11Z)-C18:1 alkyl chain.
These observations suggested that the F7 fraction contained an isomer of Lyso-PAF C18:1, and
its double bond position was tentatively assigned to C11. The 13C chemical shift values for the
allylic methylene carbon signals at 28.1 ppm indicated that the stereochemistry of the double
bond was Z. An LC/TOF-MS analysis of the F7 fraction (Table 1 and Supporting Information)
showed two major peaks at retention times (RTs) of 4.95 and 5.83 min in the base peak ion
chromatogram. The RT andm/z were identical to those of a standard sample, indicating that
the peak at RT = 5.83 corresponded to Lyso-PAF C18:0 (1). The other main peak at RT = 4.95
was probably an isomer of Lyso-PAF (9Z)-C18:1 because it had the samem/z 530 for [M+Na]+,
Fig 3. Thin-layer chromatogram of the F7 lipid fraction. The F7 lipid fraction was analyzed with Dittmer reagent (A) or 50% sulfuric acid (B) with a
chloroform–methanol–water mixture (65:35:8, v/v/v). 1, Sphingomyelin; 2, Lyso-PAF; 3, F7 lipid fraction; 4, LPC.
doi:10.1371/journal.pone.0135701.g003
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with a slightly shorter RT. Ozonolysis was performed to determine the position of the double
bond in Lyso-PAF C18:1 (RT = 4.95). To clearly identify the expected dimethyl acetal deriva-
tive, the reaction was performed in CD3OD solution. The three products were identified with
LC/TOF-MS as C11-carboxylic acid (7), C11-aldehyde (8), and its d6-dimethyl acetal deriva-
tive (9). These data are consistent with the NMR data described above. Therefore, the peak at
RT = 4.95 was identified as Lyso-PAF (11Z)-C18:1 [13,14].
Some of the minor components were inferred to be LPC based on 1H-1H correlations in the
DQF-COSY and TOCSY analyses of the glycerol and fatty acid units and the 13C NMR data
assigned from the 1H-13C HSQC and HMBC spectra. LC/TOF-MS also detected LPC C18:0
(3), LPC C16:0 (4), Lyso-PAF C16:0 (5), and Lyso-PAF C19:0, and accurately determined their
masses (Table 1 and Supporting Information). An odd number of alkyl chains in the linear
form is relatively rare, so the minor signals in the NMR spectra were analyzed carefully. In the
1H-13C HMBC spectra, a minor doublet methyl signal at 0.87 ppm showed 1H-13C long-range
correlations with carbon signals at 40.24 (CH2), 29.15 (CH), and 23.04 (CH3), and the last car-
bon was identical to the methyl carbon itself. These data, and especially the 13C NMR chemical
shift values, suggested the presence of an isopropyl group at the end of the alkyl chain. Based
on this evidence, the peak at RT = 6.23, Lyso-PAF C19:0, was tentatively assigned as the 170-
methyl derivative of Lyso-PAF C18:0 (6). In summary, NMR and LC/TOF-MS analyses identi-
fied Lyso-PAF C18:0 (1), Lyso-PAF (11Z)-C18:1 (2), LPC C18:0 (3), LPC C16:0 (4), Lyso-PAF
C16:0 (5), and 170-methyl Lyso-PAF C18:0 (6) in the F7 fraction (Fig 4). Based on the integra-
tion values of the 1H-NMR spectrum of the F7 fraction, the ratio of Lyso-PAF (compounds 1,
2, 5, and 6) to LPC (compounds 3 and 4) was 88:12. The content of the minor compound 6 in
the F7 fraction was estimated to be ca. 5% from the integration value for the doublet methyl
signal. Determining the ratio of C18:0 to C16:0, such as (1):(5) and (3):(4), was impossible with
NMR. However, the ratio of (3) or (4) was roughly estimated to be ca. 1:1 with a gas chro-
matographic analysis of the alkaline hydrolysate.
Table 1. LC/TOF-MS data for the F7 fraction and its ozonolysis products.
F7 fraction RT (min) Formula Observed m/z Theoretical [M+H]+ m/z Observed m/z Theoretical [M+Na]+ m/z
LPC C16:0 (4) 4.49 C24H50NO7P 496.3417 496.3398 518.3230 518.3217
Lyso-PAF C16:0 (5) 4.76 C24H52NO6P 482.3615 482.2605 504.3437 504.3424
Lyso-PAF (11Z)-C18:1 (2) 4.95 C26H54NO6P 508.3752 508.3762 530.3581 530.3581
LPC C18:0 (3) 5.57 C26H54NO7P 524.3742 524.3711 546.3538 546.3530
Lyso-PAF C18:0 (1) 5.83 C26H56NO6P 510.3920 510.3918 532.3733 532.3737
Lyso-PAF 17'-Me-C18:0 (6) 6.23 C27H58NO6P 524.4068 524.4075 546.3897 546.3894
standard samples RT (min) formula Observe m/z Theoretical [M+H]+ m/z Observed m/z Theoretical [M+Na]+ m/z
LPC C16:0 (4) 4.49 C24H50NO7P 496.3395 496.3398 518.3223 518.3217
LPC (9Z)-C18:1 4.76 C26H52NO7P 522.3547 522.3554 544.3392 544.3374
Lyso-PAF (9Z)-C18:1 5.00 C26H54NO6P 508.3744 508.3762 530.3583 530.3581
LPC C18:0 (3) 5.55 C26H54NO7P 524.3706 524.3711 546.3537 546.3530
Lyso-PAF C18:0 (1) 5.85 C26H56NO6P 510.3920 510.3918 532.3735 532.3737
ozonolysis products of F7 fraction RT (min) formula Observe m/z Theoretical [M+H]+ m/z Observed m/z Theoretical [M+Na]+ m/z
C11-carboxylic acid (7) 0.70 C19H40NO8P 442.2568 442.2564 ND
C11-aldehyde (8) 0.78 C19H40NO7P 426.2614 462.2615 ND
C11-d6-dimethyl acetal (9) 1.01 C21H40D6NO8P 478.3390 478.3410 ND
ND; not done.
doi:10.1371/journal.pone.0135701.t001
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Roles of Lyso-PAF and LPC in the cytoprotective and antioxidative
activities of F7
Commercially available C18 lipids were tested to confirm the roles of Lyso-PAF and LPC in
the cytoprotection of J774A.1 cells (Fig 5). Treatment of the J774A.1 cells with the F7 fraction
or with a 10 μg/mL lipid mixture containing Lyso-PAF C18:0 (44%), Lyso-PAF (9Z)-C18:1
(44%), and LPC C18:0 (12%) significantly increased cell viability in the presence of H2O2 com-
pared with that of cells not treated with the lipids. However, treatment with Lyso-PAF C18:0,
Lyso-PAF (9Z)-C18:1, or LPC C18:0 alone exerted no cytoprotective effect against H2O2 stress.
In contrast, the ORAC assay revealed that Lyso-PAF (9Z)-C18:1 and LPC C18:0 each had anti-
oxidative activity (Fig 6). These data indicate that the additive effects of Lyso-PAF and LPC
may be required for their cytoprotective effect against oxidative stress.
Fig 4. Structures of lysophospholipids.Compounds 1–6were identified as Lyso-PAF and LPC in the F7
lipid fraction. Compounds 7–9 were the products of ozonolysis.
doi:10.1371/journal.pone.0135701.g004
Lysophospholipids from Sea Cucumber
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Discussion
Various species of invertebrates contain large amounts of both phosphocholine and phos-
phoethanolamine. Platelet-activating factor (PAF)-like lipids are also widely distributed among
Fig 5. Viability of J774A.1 cells treated with LPC or Lyso-PAF. J774A.1 cells were preincubated with LPC or Lyso-PAF for 12 h, and H2O2 was then
added to the cells (25 μM). After 12 h, cell viability was measured and is expressed as the mean viability ± standard deviation of triplicate experiments. (A) F7
lipid fraction. (B) Lipid mixture containing Lyso-PAF C18:0 (44%), Lyso-PAF (9Z)-C18:1 (44%), and LPC C18:0 (12%). (C) Lyso-PAF C18:0. (D) Lyso-PAF
(9Z)-C18:1. (E) LPC. (*) Significant (P < 0.05) according to ANOVA followed by Tukey’s multiple comparisons.
doi:10.1371/journal.pone.0135701.g005
Lysophospholipids from Sea Cucumber
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various invertebrates. Therefore, phospholipids, including PAF, may be physiologically impor-
tant molecules, particularly for invertebrates [15]. In this study, we detected Lyso-PAF and
LPC in the lipid fraction with antioxidative activity extracted from the sea cucumber H. atra
for the first time. NMR and LC/TOF-MS analyses identified Lyso-PAF C18:0 (1), Lyso-PAF
(11Z)-C18:1 (2), LPC C18:0 (3), LPC C16:0 (4), Lyso-PAF C16:0 (5), and 170-methyl Lyso-
PAF C18:0 (6) in the bioactive fraction. A Lyso-PAF-related molecule has also been detected in
the sea cucumber Cucumaria frondosa [16]. Interestingly, a series of Lyso-PAF analogues and
LPCs were isolated from the marine sponge Spirastrella abata [14]. LPC C16:0 and Lyso-PAF
(11Z)-C18:1 have also been identified in S. abata [14] and an Australian sponge, Crella incru-
stans [17]. These results suggest that Lyso-PAF analogues and LPCs are widely distributed
among marine invertebrates, and some compounds may be species-specific.
Lyso-PAF is produced when PAF is cleaved at the sn-2 position by phospholipase A2. A
highly specific PAF-acetyltransferase then adds an acetyl group to the sn-2 position to yield
PAF [18]. The presence of acetyltransferase activity has been confirmed in several marine
invertebrates [15], suggesting the biosynthesis of Lyso-PAF in the lower animals. Importantly,
lyso-PAF can act as a bioactive lipid, with functions opposite those of PAF [19]. The PAF gen-
erated by basophils induces platelet aggregation and anaphylaxis [20,21], and the PAF pro-
duced by neutrophils plays important roles in inflammation, including in the activation of
NADPH oxidase [19]. The accumulation of PAF is also thought to be a principal initiator of
neuronal dysfunction and death in human immunodeficiency virus (HIV)-associated dementia
and a secondary mediator of neural loss in ischemia and epilepsy [22,23]. Therefore, the intrin-
sic regulatory mechanisms that balance PAF activities are potential targets for therapeutic
interventions. Lyso-PAF also seems to have antioxidative activity. In this study, treatment with
Lyso-PAF C18:0 or Lyso-PAF (9Z)-C18:1 alone exerted no cytoprotective effect against H2O2
stress on J774A.1 cells. In contrast, according to an ORAC assay, Lyso-PAF (9Z)-C18:1 has
antioxidative activity. Further research is required to evaluate the different activities of satu-
rated and unsaturated Lyso-PAF.
Fig 6. ORAC assay. Antioxidant capacities of the F7 lipid fraction and a lipid mixture containing Lyso-PAF
C18:0 (44%), Lyso-PAF (9Z)-C18:1 (44%), and LPC C18:0 (12%). Lyso-PAF C18:0, Lyso-PAF (9Z)-C18:1,
and LPC are expressed in μmol Trolox equivalents (TE)/g, calculated from a Trolox standard curve.
doi:10.1371/journal.pone.0135701.g006
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In mammals, LPC is a highly abundant bioactive lysoglycerophospholipid in the circulation,
predominantly associated with albumin [24] and lipoproteins, such as oxidized low-density
lipoprotein (oxLDL) [25]. The hydrolysis of the fatty acid of membrane phosphatidylcholine at
the sn-2 position by the superfamily of phospholipase A2 enzymes generates LPC and fatty
acids [26]. Although the activity of phospholipase A2 has not been demonstrated in the sea
cucumber, the expression of phospholipase has been confirmed with a proteomic analysis in
the sea cucumber Apostichopus japonicus coelomocytes after Vibrio splendidus infection [27].
This suggests the presence of the biosynthetic pathway for LPC in the sea cucumber H. atra.
Generally, LPC is an important signaling lipid with diverse functions in inflammation. LPC is
considered a causative factor in atherosclerosis, the promotion of demyelination in the nervous
system, the induction of hepatitis, and protection from sepsis. LPC also acts as a chemoattrac-
tant signal for phagocytic cells, which function as immunoregulatory cells [28]. Our results
indicate that the treatment of J774A.1 cells with LPC C18:0 conferred no cytoprotective effect
against H2O2 stress, whereas the ORAC assay demonstrated the antioxidative activity of LPC
C18:0. Although stearoyl LPC significantly attenuates circulating high-mobility group box 1
(HMGB1) levels in endotoxemia and sepsis by suppressing the release of endotoxin-induced
HMGB1 from macrophages/monocytes [29], there has been no report of the antioxidative
activity of LPC. Therefore, the mechanism underlying the antioxidative activity of LPC must
be addressed in a future study.
Although the effects of the lysophospholipids of sea cucumbers are largely unknown, this
study has shown that Lyso-PAF and LPC in the sea cucumber H. atra have cytoprotective
activity in vitro. Importantly, the additive effects of Lyso-PAF and LPC are required for their
cytoprotective activity against oxidative stress. Among the analogues of lysophospholipids,
Lyso-PAF exhibits cancerostatic properties [30,31] and potent antimicrobial activity [32]. Our
results suggest that the combination of Lyso-PAF and LPC from the sea cucumber has activities
that can control inflammation in animals, including humans. Lyso-PAF and LPC analogues
are abundant in invertebrates and are widespread among marine invertebrates [15], so our
novel findings should prompt the investigation of the therapeutic uses of lysophospholipids
from these organisms.
Supporting Information
S1 File. Contains Table A 1H and 13C NMR data for Compounds 1–4 and 6. Fig A 1H
NMR spectra of F7 fraction, and authentic Lyso-PAF (9Z)-C18:1. Fig B 13C NMR spectra of
F7 fraction, and authentic Lyso-PAF (9Z)-C18:1 and cis-5-dodecenoic acid. Fig C DQF-COSY
spectrum of F7 fraction. Fig D TOCSY spectrum of F7 fraction. Fig E NOESY spectrum of F7
fraction. Fig F HSQC spectrum of F7 fraction. Fig G HSQC-TOCSY spectrum of F7 fraction.
Fig H 1H-13C HMBC spectrum of F7 fraction. Fig I 1H-31P HMBC spectrum of F7 fraction.
Fig J Base peak ion chromatograms and mass chromatograms on LC/TOF-MS. Fig K Mass
spectrum for RT 5.83 of F7 fraction, Lyso-PAF C18:0 (1). Fig L Mass spectrum for RT 4.95 of
F7 fraction, Lyso-PAF (11Z)-C18:1 (2). Fig MMass spectrum for RT 5.57 of F7 fraction, LPC
C18:0 (3) Fig N Mass spectrum for RT 4.49 of F7 fraction, LPC C16:0 (4) Fig O Mass spectrum
for RT 4.76 of F7 fraction, Lyso-PAF C16:0 (5). Fig P Mass spectrum for RT 6.23 of F7 fraction,
Lyso-PAF 17’- Methyl-C18:0 (6). Fig Q Mass spectrum for Lyso-PAF C18:0 (1) of a standard
mixture. Fig R Mass spectrum for Lyso-PAF (9Z)-C18:1 of a standard mixture. Fig S Mass
spectrum for LPC C18:0 (3) of a standard mixture. Fig T Mass spectrum for LPC C16:0 (4) of a
standard mixture. Fig U Mass spectrum for LPC (9Z)-C18:1 of a standard mixture. Fig V Mass
spectrum for RT 0.70 of ozonolysis products, C11-carboxylic acid (7). Fig WMass spectrum
for RT 0.78 of ozonolysis products, C11-aldehyde (8). Fig X Mass spectrum for RT 1.01 of
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ozonolysis products, C11-d6-dimethyl acetal (9).
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